A Q&A with Dr. Lynda Stuart, deputy director of Vaccines & Human Immunobiology at the Bill & Melinda Gates Foundation, moderated by Joyce Barnathan, president of ICFJ
As countries place their populations on lockdown, authorities issue stay-at-home directives, health systems are stretched, millions are unable to work, and global economic consequences mount, the race for a vaccine for COVID-19 is moving swiftly. In this Q&A with Dr. Lynda Stuart of the Bill & Melinda Gates Foundation, we discuss what approaches to vaccine development are being pursued and what stage they are in.
